RBR-7zwzs3尚未招募1 期
Efficacy and Safety of Cinnamaldehyde in the Treatment of Buccal Candidiasis associated with the use of dental prostheses: Clinical Trial, Randomized, Controlled and Blind
niversidade Federal da Paraíba0 个研究点开始时间: 2019年9月3日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 40Y 至 70Y（—）
入选标准
- •Fase I: The study will include healthy individuals and users of upper removable total prosthesis, belonging to the age group from 40 to 70 years.
- •In order for there to be no confusion of signs and symptoms relevant to possible adverse effects of the test product with signs and symptoms of disease, healthy subjects were selected as defined by the Phase I clinical trial definition.
- •fase II: Individuals belonging to the age group from 40 to 70 years old, with oral candidiasis and dental prosthesis user, with a signed and signed Free and Informed Consent Term.
排除标准
- •Fases I e II: Individuals undergoing topical and / or systemic antimicrobial treatment and who have a sensitivity reaction to cinnamaldehyde, cinnamon or Miconazole.
研究者
相似试验
尚未招募
2 期
Cinnamaldehyde Mucoadhesive PatchesCTRI/2024/02/063126VSPM DC RC
进行中（未招募）
不适用
Efficacy and safety of a fixed combination of cinnarizine 20 mg and dimenhydrinate 40 mg vs betahistine dihydrochloride 16 mg in patients with inner ear vertigo.Vertigo of peripheral originMedDRA version: 15.0Level: LLTClassification code 10031615Term: Other and unspecified peripheral vertigoSystem Organ Class: 10013993 - Ear and labyrinth disordersMedDRA version: 14.1Level: LLTClassification code 10058708Term: Rotatory vertigoSystem Organ Class: 10013993 - Ear and labyrinth disordersMedDRA version: 14.1Level: PTClassification code 10047344Term: Vertigo labyrinthineSystem Organ Class: 10013993 - Ear and labyrinth disordersMedDRA version: 14.1Level: LLTClassification code 10034641Term: Peripheral vertigo, unspecifiedSystem Organ Class: 10013993 - Ear and labyrinth disordersMedDRA version: 15.0Level: LLTClassification code 10032379Term: Other peripheral vertigoSystem Organ Class: 10013993 - Ear and labyrinth disordersEUCTR2011-004025-27-ATHENNIG ARZNEIMITTEL GmbH & Co. KG224
进行中（未招募）
1 期
Efficacy and safety of a fixed combination of cinnarizine 20 mg and dimenhydrinate 40 mg vs betahistine dihydrochloride 16 mg in patients with inner ear vertigo.Vertigo of peripheral originMedDRA version: 16.1Level: LLTClassification code 10031615Term: Other and unspecified peripheral vertigoSystem Organ Class: 10013993 - Ear and labyrinth disordersMedDRA version: 16.1Level: LLTClassification code 10058708Term: Rotatory vertigoSystem Organ Class: 10013993 - Ear and labyrinth disordersMedDRA version: 16.1Level: PTClassification code 10047344Term: Vertigo labyrinthineSystem Organ Class: 10013993 - Ear and labyrinth disordersMedDRA version: 16.1Level: LLTClassification code 10034641Term: Peripheral vertigo, unspecifiedSystem Organ Class: 10013993 - Ear and labyrinth disordersMedDRA version: 16.1Level: LLTClassification code 10032379Term: Other peripheral vertigoSystem Organ Class: 10013993 - Ear and labyrinth disordersEUCTR2011-004025-27-BGHENNIG ARZNEIMITTEL GmbH & Co. KG224
进行中（未招募）
1 期
Efficacy and safety of a fixed combination of cinnarizine 20 mg and dimenhydrinate 40 mg vs betahistine dihydrochloride 16 mg in patients with inner ear vertigo.EUCTR2011-004025-27-CZHENNIG ARZNEIMITTEL GmbH & Co. KG306
已完成
不适用
Comparing cinnamon mouthwash with chlorhexidine mouthwashCTRI/2018/01/011587Aditi Hegde70